150 related articles for article (PubMed ID: 20656046)
1. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review.
Oliansky DM; Czuczman M; Fisher RI; Irwin FD; Lazarus HM; Omel J; Vose J; Wolff SN; Jones RB; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2011 Jan; 17(1):20-47.e30. PubMed ID: 20656046
[TBL] [Abstract][Full Text] [Related]
2. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review.
Hahn T; Wingard JR; Anderson KC; Bensinger WI; Berenson JR; Brozeit G; Carver JR; Kyle RA; McCarthy PL
Biol Blood Marrow Transplant; 2003 Jan; 9(1):4-37. PubMed ID: 12533739
[TBL] [Abstract][Full Text] [Related]
3. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review.
Oliansky DM; Gordon LI; King J; Laport G; Leonard JP; McLaughlin P; Soiffer RJ; van Besien KW; Werner M; Jones RB; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2010 Apr; 16(4):443-68. PubMed ID: 20114084
[TBL] [Abstract][Full Text] [Related]
4. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review.
Oliansky DM; Larson RA; Weisdorf D; Dillon H; Ratko TA; Wall D; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2012 Jan; 18(1):18-36.e6. PubMed ID: 21803017
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.
Rigacci L; Puccini B; Dodero A; Iacopino P; Castagna L; Bramanti S; Ciceri F; Fanin R; Rambaldi A; Falda M; Milone G; Guidi S; Martelli MF; Mazza P; Oneto R; Bosi A;
Ann Hematol; 2012 Jun; 91(6):931-9. PubMed ID: 22245922
[TBL] [Abstract][Full Text] [Related]
6. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review.
Biol Blood Marrow Transplant; 2011 Jan; 17(1):18-9. PubMed ID: 21056108
[No Abstract] [Full Text] [Related]
7. Comparison of outcomes after auto-SCT for patients with relapsed diffuse large B-cell lymphoma according to previous therapy with rituximab.
Smith SD; Bolwell BJ; Rybicki LA; Kang T; Dean R; Advani A; Thakkar S; Sobecks R; Kalaycio M; Pohlman B; Sweetenham JW
Bone Marrow Transplant; 2011 Feb; 46(2):262-6. PubMed ID: 20479706
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic stem cell transplantation in patients with de novo diffuse large B-cell lymphoma who experienced relapse or progression after autologous stem cell transplantation: a Korea-Japan collaborative study.
Kim JW; Kim SW; Tada K; Fukuda T; Lee JH; Lee JJ; Kwon JH; Bang SM; Kim I; Yoon SS; Lee JS; Park S
Ann Hematol; 2014 Aug; 93(8):1345-51. PubMed ID: 24633661
[TBL] [Abstract][Full Text] [Related]
9. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B.
Nademanee A; Forman SJ
Semin Hematol; 2006 Oct; 43(4):240-50. PubMed ID: 17027658
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic stem cell transplantation for diffuse large B cell lymphoma: defining the role of allografts.
Uhm J; Kuruvilla J
Transfus Apher Sci; 2013 Aug; 49(1):63-71. PubMed ID: 23790650
[TBL] [Abstract][Full Text] [Related]
11. Recent progress: hematopoietic cell transplant for diffuse large B-cell lymphoma.
Farooq U; Laport GG
Leuk Lymphoma; 2015 Jul; 56(7):1930-7. PubMed ID: 25315072
[TBL] [Abstract][Full Text] [Related]
12. Role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review.
Oliansky DM; Camitta B; Gaynon P; Nieder ML; Parsons SK; Pulsipher MA; Dillon H; Ratko TA; Wall D; McCarthy PL; Hahn T;
Biol Blood Marrow Transplant; 2012 Apr; 18(4):505-22. PubMed ID: 22209888
[TBL] [Abstract][Full Text] [Related]
13. [Role of high-dose chemotherapy and autologous blood stem cell transplantation in patients with diffuse large B-cell lymphoma].
Gavrilina OA; Gabeeva NG; Morozova AK; Sidorova AA; Zvonkov EE
Ter Arkh; 2013; 85(7):90-7. PubMed ID: 24137955
[TBL] [Abstract][Full Text] [Related]
14. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review.
Hahn T; Wall D; Camitta B; Davies S; Dillon H; Gaynon P; Larson RA; Parsons S; Seidenfeld J; Weisdorf D; McCarthy PL
Biol Blood Marrow Transplant; 2006 Jan; 12(1):1-30. PubMed ID: 16399566
[TBL] [Abstract][Full Text] [Related]
15. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
Oliansky DM; Rizzo JD; Aplan PD; Arceci RJ; Leone L; Ravindranath Y; Sanders JE; Smith FO; Wilmot F; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2007 Jan; 13(1):1-25. PubMed ID: 17222748
[TBL] [Abstract][Full Text] [Related]
16. Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.
Villa D; George A; Seymour JF; Toze CL; Crump M; Lee C; Buckstein R; Stewart DA; MacDonald D; Foley R; Xenocostas A; Sabloff M; Chua N; Couture F; Larouche JF; Cohen S; Savage KJ; Connors JM; Panzarella T; Carney DA; Dickinson M; Kuruvilla J
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1813-8. PubMed ID: 25042735
[TBL] [Abstract][Full Text] [Related]
17. Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study.
van Imhoff GW; McMillan A; Matasar MJ; Radford J; Ardeshna KM; Kuliczkowski K; Kim W; Hong X; Goerloev JS; Davies A; Barrigón MDC; Ogura M; Leppä S; Fennessy M; Liao Q; van der Holt B; Lisby S; Hagenbeek A
J Clin Oncol; 2017 Feb; 35(5):544-551. PubMed ID: 28029326
[TBL] [Abstract][Full Text] [Related]
18. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
Papajik T; Raida L; Faber E; Vondrakova J; Prochazka V; Kubova Z; Skoumalova I; Jarosova M; M LK; Paucek B; Myslivecek M; Neoral C; Oral I; Jarkovsky J; Dusek L; Indrak K
Neoplasma; 2008; 55(3):215-21. PubMed ID: 18348654
[TBL] [Abstract][Full Text] [Related]
19. Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method.
Gutiérrez-Aguirre CH; Ruiz-Argüelles G; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; García-Rodríguez F; López-Otero A; Herrera-Garza JL; Gómez-Almaguer D
Ann Hematol; 2010 Oct; 89(10):1045-52. PubMed ID: 20490794
[TBL] [Abstract][Full Text] [Related]
20. The role of allogeneic haematopoietic progenitor cell transplantation in patients with diffuse large B-cell non-Hodgkin lymphomas (DLBCL).
Papageorgiou SG; Cwynarski K; Kottaridis PD
Bone Marrow Transplant; 2013 Oct; 48(10):1271-8. PubMed ID: 23318539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]